News

VivaVision Biotech Welcomes Leading Ophthalmology Expert

VivaVision Biotech Welcomes Leading Ophthalmology Expert

VivaVision Biotech Strengthens Advisory Board with Expert

Recently, VivaVision Biotech Co., Ltd. (VivaVision) proudly announced the addition of Dr. Quan Dong Nguyen, a globally recognized figure in the field of ophthalmology, to its Scientific Advisory Board. This strategic appointment marks a significant step forward for the company as it furthers its commitment to innovative eye care solutions.

Meet Dr. Quan Dong Nguyen

Dr. Quan Dong Nguyen is currently affiliated with the Byers Eye Institute at Stanford University, where he serves as a professor of ophthalmology and has further appointments in medicine and pediatrics. His research primarily revolves around clinical trials for macular edema, neovascular age-related macular degeneration (AMD), and various ocular inflammatory diseases. Having pioneered evaluations of drugs like aflibercept and ranibizumab, Dr. Nguyen's contributions are foundational in establishing effective treatment protocols for retinal problems.

Impact on VivaVision's Projects

Dr. Nguyen's expertise is expected to significantly enhance VivaVision's research and development initiatives. He expressed enthusiasm about joining the team and highlighted the potential of VivaVision's dual JAK1/TYK2 inhibitors, VVN461 and VVN481, developed for treating ocular inflammatory conditions. These innovative therapies aim to provide patients with safer alternatives to current corticosteroid treatments.

Comments from Leadership

Wang Shen, the Founder and CEO of VivaVision Biotech, expressed honor at having Dr. Nguyen join the advisory board. He emphasized that Dr. Nguyen’s extensive knowledge in managing conditions such as diabetic macular edema and inflammatory diseases will be invaluable as VivaVision continues to expand its research endeavors.

About VivaVision

Established in 2016, VivaVision Biotech focuses on pioneering clinical therapies for ocular diseases. With a commitment to addressing unmet medical needs, the company is advancing leading-edge treatments, including:

Innovative Pipeline Developments

1. VVN461: A dual JAK1/TYK2 immunomodulator designed to manage post-operative inflammation and non-infectious anterior uveitis.

2. VVN001: An investigational remedy for dry eye disease.

3. VVN1901: Targeted treatment for neurotrophic keratitis.

4. VVN481: A non-steroidal treatment for posterior uveitis and related inflammatory conditions.

In addition, VivaVision is dedicated to discovering groundbreaking therapies that tackle both anterior and posterior ocular diseases, effectively addressing the challenges faced by patients worldwide.

Frequently Asked Questions

What is the significance of Dr. Quan Dong Nguyen's appointment?

Dr. Nguyen's experience in clinical trials and ocular diseases strengthens VivaVision's advisory board, enhancing its research capabilities.

What are VVN461 and VVN481?

These are dual JAK1/TYK2 inhibitors aimed at treating ocular inflammatory diseases and offer new options for patients.

When was VivaVision Biotech founded?

VivaVision Biotech was founded in 2016 with a focus on developing innovative therapies for eye diseases.

What conditions does VivaVision's pipeline aim to treat?

VivaVision's pipeline focuses on various ocular diseases, including dry eye disease, inflammation, and retinal disorders.

How does VivaVision approach research and development?

The company emphasizes innovative strategies to address unmet patient needs in ocular health through advanced therapies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Seasonal Hiring Booms as Firms Eye Long-Term Talent

Updated Category News Views 145

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

Continue Reading
Banco Macro S.A. Plans $160B Share Buyback Initiative

Updated Category News Views 24

Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...

Continue Reading
Insurify's AI Gateway: A New Era in Insurance Shopping

Updated Category News Views 90

Insurify's Game-Changing AI Agent Gateway In the insurance world, Insurify's latest move feels like a bull charging through a ticker tape parade. This Cambridge-based pioneer unveiled its AI Agent Gateway, aiming to put consumers back in the driver's seat. By connecting digital assistant agents to its platform, Insurify's making insurance shopping a bit less like pulling...

Continue Reading
MetroScape: Local Roots Fuel Bold DFW Growth Plans

Updated Category News Views 145

A Local Business with Big Aspirations Here's the deal, folks: Local guys Dr. Marc Nickell and Chris Brewer snatched up MetroScape Landscape like it was the last slice of grandma's pie. Why? Not just for the greenbacks—they're putting down roots in their very own backyard, the Dallas-Fort Worth area. What Does Local Really Mean? Look, it's one thing hitting up a...

Continue Reading
Water UP! Celebrates Five Years, 61 Graduate So Far

Updated Category News Views 46

Reflecting on Five Years of Water UP! New Jersey American Water's workforce development initiative, Water UP!, is painting a picture of success as it marks its fifth year. The program celebrated its 2026 graduating class at the Camden headquarters—a milestone with both numbers and faces as evidence of its impact. A Closer Look at the Journey It’s not just about a...

Continue Reading
Infinite Electronics Reveals Cutting-Edge Connectivity at Electronica

Updated Category News Views 102

Infinite Electronics Makes Waves at Electronica 2026 Let’s get down to brass tacks: Infinite Electronics is setting up one heck of a show at the electronica 2026 in Munich from November 10–13. They're not just there to give out free pens—these guys mean business with connectivity products that cover everything from drones to industrial automation. A Showcase of...

Continue Reading
Temu Joins DBI to Boost Irish Digital Business Growth

Updated Category News Views 22

You know it's a lively day when Temu, the big fish in the e-commerce pond, decides to dive into Ireland's digital waters by joining forces with Digital Business Ireland (DBI). Yeah, we're talking about more than just a handshake here. If you’re wondering why this matters, keep your ears open to the whispers of opportunity. Temu's addition isn't just a membership; it's a...

Continue Reading
Nikon Unveils Game-Changing Zoom Lens for Pros

Updated Category News Views 35

Nikon Raises the Bar with New Pro Zoom Lens Well, Nikon's done it again, folks. They've dropped the NIKKOR Z 120-300mm f/2.8 TC VR S lens, and it looks like they're giving photographers something to drool over. Now, before you start rolling your eyes, this isn't just another shiny gadget. This bad boy is lighter and faster than anything Nikon's thrown at us before, and it...

Continue Reading
Lilly Taps AI for Alzheimer’s Research with SpeechDx

Updated Category News Views 96

Some folks might just brush off a little forgetfulness as old age, but what if we could pinpoint Alzheimer's up front with just the way someone talks? That’s the big league play Eli Lilly's making by licensing the SpeechDx dataset from the Alzheimer's Drug Discovery Foundation (ADDF). This ain't your run-of-the-mill data—it's the largest harmonized longitudinal...

Continue Reading
Minesto Charts Bold Tides with Dragon Farms Funding

Updated Category News Views 19

Minesto’s making waves, folks, and it ain’t just its tech splashing around. This Swedish tidal power ace is strutting on the global stage, flexing some serious muscle with projects that mean business. From the dragon-taming Faroe Islands to the Irish coasts, they’re pushing the envelope on tidal energy, and investors might wanna take note. Dragon Power Unleashed:...

Continue Reading

Top 5 Most Recently Viewed Articles

Citi Research Places Buy Rating on Alstom with Risks Noted

Updated Category News Views 85

Citi Research Assigns Buy Rating to Alstom, Highlighting Risks Citi Research has recently given Alstom (EPA: ALSO) a high-risk Buy rating, establishing a price target of €22, while the current market price sits at €16.10. This noteworthy rating arises amidst mixed performance signals from the company. Although Alstom shares have faced some obstacles, largely due to...

Continue Reading
Hennessy Advisors Reevaluates Executive Pay Structure for Growth

Updated Category News Views 68

Hennessy Advisors Announces Changes to Executive Compensation Hennessy Advisors, Inc. has recently announced some updates to the compensation plans for its key executives via an official filing. Starting October 1, Neil J. Hennessy, the firm's founder and a prominent leader, will see his quarterly incentive bonus change from 6.5% to 5.0% of the pre-tax profits. On the...

Continue Reading
Exploring the Best Dividend Stocks for Reliable Income

Updated Category News Views 75

Many investors have been drawn to the allure of dividends, providing passive income that complements their earnings. Strong dividend stocks typically stem from companies with solid business models, positive cash flow, and a commitment to sharing profits. But potential investors should always look beyond mere payouts when evaluating these stocks. Companies with a proven...

Continue Reading
Kathleen Hinn Celebrated as a Pinnacle Professional Member

Updated Category News Views 154

Kathleen Hinn Recognized as a Pinnacle Professional Member Prominently featured in the Inner Circle, Kathleen Hinn is honored as a Pinnacle Professional Member for her exceptional contributions to the real estate industry over the past five decades. A Trusted Name in Real Estate Kathleen Hinn has established herself as a prominent figure in both residential and commercial...

Continue Reading
Performance Shipping Secures $100 Million in Bond Offering Success

Updated Category News Views 139

Performance Shipping Achieves Major Bond Offering Milestone Performance Shipping Inc. (NASDAQ: PSHG), a prominent player in the shipping sector, recently announced a significant achievement—a successful placement of $100 million in bonds within the Nordic bond market. This strategic move not only reinforces the company’s financial positioning but also reflects its...

Continue Reading